Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose
- PMID: 947654
- DOI: 10.1002/cpt1976202219
Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose
Abstract
A simple and senstitive radioimmunoassay has been developed for the determination of antipyrine levels in plasma and saliva of man. Antiserum to antipyrine was obtained from rabbits immunized with an immunogen prepared by covalently coupling N-(4-antipyrinyl)-succinamic acid to bovine serum albumin (BSA). The radioimmunoassay can detect antipyrine levels as low as 10 ng/ml of plasma or saliva, using a 0.1-ml sample. This contrasts with the sensitivity of a commonly used spectrophotometric method that can measure about 4,000 ng/ml using a 2-ml plasma sample. Agreement between the radioimmunoassay and spectrophotometric assay of antipyrine was excellent for plasma (r = 0.98) and salvia (r =0.97) when samples were analyzed from 6 subjects receiving 18 mg/kg of antipyrine. The correlation between plasma and saliva antipyrine half-lives using the radioimmunoassay and an 18 mg/kg dose of antipyrine was r = 0.90 (p less than 0.005). After a dose of 1.8 mg/kg of antipyrine, the drug disappeared monoexponentially from plasma and saliva for at least 51 hr, and the correlation between plasma half-life and saliva half-life was r = 0.97 (p less than 0.001) in the 6 subjects. Excellent agreement was also observed between half-lives after the high and low doses of antipyrine (r = 0.99, p less than 0.001 for plasma and r = 0.98, p less than 0.001 for saliva).
Similar articles
-
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.Pharmacology. 1979;18(4):210-23. doi: 10.1159/000137254. Pharmacology. 1979. PMID: 461498
-
Assessment of antipyrine kinetics by measurement in saliva.Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x. Br J Clin Pharmacol. 1976. PMID: 973966 Free PMC article.
-
Plasma antipyrine half-life can be determined from urine data.Br J Clin Pharmacol. 1987 Jun;23(6):715-9. doi: 10.1111/j.1365-2125.1987.tb03106.x. Br J Clin Pharmacol. 1987. PMID: 2440468 Free PMC article.
-
Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.Eur J Clin Pharmacol. 1976 Feb 6;9(4):327-32. doi: 10.1007/BF00561668. Eur J Clin Pharmacol. 1976. PMID: 971716
-
Factors influencing antipyrine elimination.Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x. Br J Clin Pharmacol. 1977. PMID: 332216 Free PMC article. Review. No abstract available.
Cited by
-
Nutrition-endocrine interactions: induction of reciprocal changes in the delta 4-5 alpha-reduction of testosterone and the cytochrome P-450-dependent oxidation of estradiol by dietary macronutrients in man.Proc Natl Acad Sci U S A. 1983 Dec;80(24):7646-9. doi: 10.1073/pnas.80.24.7646. Proc Natl Acad Sci U S A. 1983. PMID: 6584878 Free PMC article.
-
Effect of vitamin C supplement on antipyrine disposition in man.Br J Clin Pharmacol. 1977 Apr;4(2):236-9. doi: 10.1111/j.1365-2125.1977.tb00701.x. Br J Clin Pharmacol. 1977. PMID: 861139 Free PMC article. No abstract available.
-
Therapeutic drug monitoring in saliva.Clin Pharmacokinet. 1978 Jan-Feb;3(1):39-57. doi: 10.2165/00003088-197803010-00003. Clin Pharmacokinet. 1978. PMID: 25155 Review. No abstract available.
-
Oral absorption and secretion of drugs.Br J Clin Pharmacol. 1977 Apr;4(2):97-100. doi: 10.1111/j.1365-2125.1977.tb00678.x. Br J Clin Pharmacol. 1977. PMID: 324505 Free PMC article. Review. No abstract available.
-
The effect of rifampicin on norethisterone pharmacokinetics.Eur J Clin Pharmacol. 1979 Apr 17;15(3):193-7. doi: 10.1007/BF00563105. Eur J Clin Pharmacol. 1979. PMID: 37091